| Abbott’s HeartMate LVADs recalled again over screen issues—FDA highlights significant risks |
| Mechanical valves linked to superior long-term survival after tricuspid valve replacement |
| Why your cardiology department's leadership structure matters |
| Biden Administration lowers prices for 64 prescription drugs, including 3 prescribed by cardiologists |
| FDA clears new AI algorithm for 1-year AFib risk |
| Dual approvals: AliveCor gains FDA clearance for advanced AI model, handheld ECG system |
| Bring on the veggie burgers? Replacing meat with plant-based alternatives may boost heart health |
| Routine stress tests after PCI make little difference, even in high-risk ACS patients |
| How persistent AFib impacts TAVR survival |
| Energy drinks and sudden cardiac arrest: There’s smoke, and there may be fire |
| A historic moment in diabetes care: Teva launches first-ever generic GLP-1 in US |
| New editor shares vision for ACC’s flagship journal: ‘Chasing impact, not impact factor’ |
| Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards? |
| AI-powered platform for arrhythmia detection gains FDA approval |
| FDA approves new pulmonary artery sensor for heart failure |
| Semaglutide improves heart failure symptoms in both sexes—weight loss greater in women |
| A cardiologist's guide to treating pulmonary embolism |
| New 5:2 intermittent fasting diet bests metformin, empagliflozin in patients with early-stage type 2 diabetes |
| Heart surgeons are fed up with old technology—many have considered a career change |
| Risk of death from CVD skyrockets when women use cannabis |
| The future of electrophysiology: Reviewing key trends in PFA |
| AI can help cardiologists predict death after TAVR—but there is a catch |
| FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as ‘tip of the iceberg’ |
| The waiting game: Delaying TAVR increases healthcare costs by $10K per year |
| Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists |
| Boston Scientific to acquire medical device specialists focused on stroke prevention for $1.2B |
| Interventional cardiology sees growing role in pulmonary embolism interventions |
| 1.6 million excess Black deaths owed to inequities in cardiac care, JACC report card reveals |
| ASNC supports AMA effort to limit use of AI in prior authorization decisions |
| How long do wearable cardiac monitors record data? |
| Stretching may help reduce painful orthopedic issues among echo and interventional lab staff |
| CDC-funded program improved cardiovascular health of low-income Nebraska women |
| First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage |
| New avenue for regenerating damaged heart cells discovered |
| Patient deaths and injuries prompt Teleflex to recall intra-aortic balloon catheters |
| Cardiovascular ultrasound innovations being showcased at ASE 2024 meeting |
| Using ECG AI to find the cardiac amyloidosis needles in the haystack |
| Addressing staffing shortages in cardiology |
| Cardiologist-supported prior authorization reform reintroduced in Congress |
| Medical device company raises $104M to fund PFA research |
| Even moderate alcohol use increases risk of high blood pressure, new meta-analysis confirms |
| TAVR vs. SAVR for low-risk patients: Cardiologist explores the decision-making process |
| FDA warns against ‘microdosing’ with mushroom chocolates due to heart issues, other health risks |
| New-look polymer mitral valve linked to positive outcomes 30 days after surgery |
| Telemedicine, remote monitoring help reduce healthcare costs |
| Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes |
| ‘Different products for different people’: FDA clears 2 Abbott over-the-counter glucose monitors |
| How cardiologists and hospitals get paid |
| Cardiologist Stuart Connolly remembered as a ‘generational thinker,’ electrophysiology pioneer |
| Interest growing in fluoroscopy-free workflows during RF ablation |
| Medtronic TAVR valves at heart of multiple sessions during New York cardiology conference |
| Embracing AI to enhance EP: Insights from cardiologist Jagmeet Singh |
| Private equity in healthcare: Cardiologists, government officials and advocacy groups share their perspective |
| Edwards shares new data highlighting consistency of its TAVR valves in women, patients with small annuli |
| Another common artificial sweetener linked to higher risk of heart attack, stroke |
| Mediterranean diet helps women live longer, reducing heart disease and cancer risks |
| Engineers team with cardiologist to rethink heart pump assessments |
| Eko Health raises $41M to expand footprint of its AI-powered stethoscopes |
| Heart Rhythm Society shows support for new cardiovascular board, outpatient EP centers |
| AI uses imaging results to ID high-risk TAVR patients with speed, accuracy |
| Key trends in electrophysiology include PFA, dual-chamber leadless pacemakers |
| 3 in 5 US adults projected to have CVD by 2050, with a price tag of $1.8T—can cardiologists ‘turn the tide’? |
| AI-based coronary plaque assessments 1 step closer to Medicare coverage |
| New one-stop cardiology clinic focuses on patient relationships, not insurance |
| Edwards Lifesciences sells critical care business to BD for $4.2B—remains ‘laser focused’ on structural heart disease |
